Long‐acting beta2‐agonist in addition to tiotropium versus either tiotropium or long‐acting beta2‐agonist alone for chronic obstructive pulmonary disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Long‐acting Beta2‐agonist in Addition to Tiotropium Versus Either Tiotropium or Long‐acting Beta2‐agonist Alone for Chronic Obstructive Pulmonary Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438864/1/. Accessed 02 May 2024.
Long‐acting beta2‐agonist in addition to tiotropium versus either tiotropium or long‐acting beta2‐agonist alone for chronic obstructive pulmonary disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438864/1/. Accessed May 2, 2024.
Long‐acting beta2‐agonist in addition to tiotropium versus either tiotropium or long‐acting beta2‐agonist alone for chronic obstructive pulmonary disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438864/1/
Long‐acting Beta2‐agonist in Addition to Tiotropium Versus Either Tiotropium or Long‐acting Beta2‐agonist Alone for Chronic Obstructive Pulmonary Disease [Internet]. In: Cochrane Abstracts. [cited 2024 May 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438864/1/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Long‐acting beta2‐agonist in addition to tiotropium versus either tiotropium or long‐acting beta2‐agonist alone for chronic obstructive pulmonary disease
ID - 438864
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438864/1/
DB - Evidence Central
DP - Unbound Medicine
ER -